Your phone camera may soon double as a clinical movement lab.
A research team developed Quantitative Movement Testing (QMT), a computer vision pipeline that pulls 3D kinematic data from standard monocular smartphone video. They validated it against optical motion capture — the gold-standard, lab-only system that costs far more to operate — using 13 healthy controls, then deployed it in two clinical cohorts: fibromyalgia patients in a pre- and post-intervention trial, and chronic sciatica patients tracked at home over 30 days. In lab conditions, QMT hit strong correlations (r > 0.85) against optical capture and showed high test-retest reliability (r > 0.86) in fibromyalgia patients. It also detected group-level movement differences between sciatica patients and healthy controls using only remote home recordings.
Chronic pain is notoriously hard to measure objectively. Patients self-report, clinicians observe, and neither method scales well for ongoing monitoring or clinical trials. A validated tool that runs on hardware already in a patient's pocket removes both the lab bottleneck and the cost barrier — and produces quantitative biomarkers that don't rely on someone describing their pain on a scale of one to ten.
The caveat the researchers flag themselves: home environments introduced more measurement variance than the lab. That gap will need closing before QMT can anchor a regulatory submission or replace motion capture in high-stakes assessments — but as a low-cost screening and monitoring layer, it has a clearer path to adoption than most academic prototypes.